STUDY OF THE SPECIFIC ACTIVITY OF ANTIDIABETIC DRUG ON THE BASIS OF (Z)-ETHYL 2-(4-(4-CHLORPHENYL)-2,4-DIOXO-3-(3-OXO-3,4-DIHYDROQUINOXALINE-2(1H)-ILIDEN)BUTANAMIDE)-4-METHYL-5-PHENYLTHIOPHENE-3-CARBOXYLATE
Presents data on the pharmacological activity of (Z)-ethyl 2-(4-(4-chlorphenyl)-2,4-dioxo-3-(3-oxo-3,4-dihydroquinoxaline-2(1Н)-iliden)butanamide)-4-methyl-5-phenylthiophene-3-carboxylate (glycitin). In the experiments on the old 2-year-old rats showed the ability of the drug to increase tolerance to a glucose load, to potentiate the hypoglycemic action of insulin and improve blood lipids.